Palisade Capital Management LLC Avadel Pharmaceuticals PLC Transaction History

Palisade Capital Management LLC

  • $3.22 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 12, 2019
SELL
$1.74 - $4.66 $46,980 - $125,820
-27,000 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$4.08 - $7.14 $48,960 - $85,680
12,000 Added 80.0%
27,000 $119,000
Q2 2018

Aug 13, 2018
BUY
$5.89 - $7.78 $23,560 - $31,120
4,000 Added 36.36%
15,000 $92,000
Q1 2018

May 09, 2018
BUY
$6.76 - $11.7 $74,360 - $128,699
11,000 New
11,000 $80,000

Others Institutions Holding AVDL

# of Institutions
8
Shares Held
1.07M
Call Options Held
0
Put Options Held
0
View Full List

About AVADEL PHARMACEUTICALS PLC

AVDL Quotes by TradingView
  • Ticker AVDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,581,300
  • Market Cap $626M
  • Description
  • Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...
More about AVDL
Track This Portfolio

Track Palisade Capital Management LLC Portfolio

Follow Palisade Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email